|
Volume 272, Number 52, Issue of December 26, 1997
pp. 32798-32803
Aortic Smooth Muscle Cells Interact with Tenascin-C through Its
Fibrinogen-like Domain
(Received for publication, August 11, 1997, and in revised form, October 8, 1997)
David W.
LaFleur
,
Julie
Chiang
,
James A.
Fagin
,
Stephen M.
Schwartz
,
Prediman K.
Shah
,
Kurt
Wallner
,
James S.
Forrester
and
Behrooz G.
Sharifi
From the Atherosclerosis Research Center, Division of Cardiology,
Burns and Allen Research Institute, Cedar-Sinai Medical Center,
University of California School of Medicine, Los Angeles, California
90048 and Division of Pathology, University of
Washington, Seattle, Washington 98195
The extracellular matrix protein tenascin-C is a
multidomain protein that regulates cell adhesion. We used two different
smooth muscle cell subtypes derived from adult and newborn rat aorta to
investigate the interaction of tenascin-C or its various domains with
these cells using an adhesion assay. Newborn cells were three times
more adherent to tenascin-C than adult cells. Tenascin C-adhering cells
remained round, whereas they spread rapidly on a fibronectin substrate.
Adhesion assays showed the interaction between tenascin-C and newborn
cells to be predominantly RGD-independent. Mg2+
increased newborn cell adhesion to tenascin-C in a
concentration-dependent manner, whereas Ca2+
had no effect. To analyze the structure-function relationships of
different domains of tenascin-C, we used recombinant full-length fibronectin-like and fibrinogen-like domains and various subdomains corresponding to the alternatively spliced regions of tenascin-C. The
cells adhered to the fibrinogen-like domain but not to the fibronectin-like domain or its subdomains. As with the intact tenascin-C molecule, adherent cells remained round, and the
Mg2+, but not Ca2+, promoted this interaction.
The interaction of cells with the fibrinogen-like region was further
mapped to a 30-amino acid peptide located near the carboxyl-terminal
part of the tenascin-C molecule. The same 30-amino acid peptide was
active in promoting cell migration. Our results provide a basis for
understanding the mechanism of interaction of tenascin-C with smooth
muscle cells and a framework for isolating membrane binding sites that
mediate the cellular responses to this molecule.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Sawada, K. Onoda, K. Imanaka-Yoshida, J. Maruyama, K. Yamamoto, T. Yoshida, and H. Shimpo
Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis
Cardiovasc Res,
June 1, 2007;
74(3):
366 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tamaoki, K. Imanaka-Yoshida, K. Yokoyama, T. Nishioka, H. Inada, M. Hiroe, T. Sakakura, and T. Yoshida
Tenascin-C Regulates Recruitment of Myofibroblasts during Tissue Repair after Myocardial Injury
Am. J. Pathol.,
July 1, 2005;
167(1):
71 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamamoto, K. Onoda, Y. Sawada, K. Fujinaga, K. Imanaka-Yoshida, H. Shimpo, T. Yoshida, and I. Yada
Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice
Cardiovasc Res,
February 15, 2005;
65(3):
737 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fujinaga, K. Onoda, K. Yamamoto, K. Imanaka-Yoshida, M. Takao, T. Shimono, H. Shimpo, T. Yoshida, and I. Yada
Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-c synthesis and smooth muscle cell proliferation in free artery grafts
J. Thorac. Cardiovasc. Surg.,
September 1, 2004;
128(3):
357 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wallner, C. Li, P. K. Shah, K.-J. Wu, S. M. Schwartz, and B. G. Sharifi
EGF-Like Domain of Tenascin-C Is Proapoptotic for Cultured Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2004;
24(8):
1416 - 1421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Qin, Z. Zeng, J. Zheng, P. K. Shah, S. M. Schwartz, L. D. Adams, and B. G. Sharifi
Suppression Subtractive Hybridization Identifies Distinctive Expression Markers for Coronary and Internal Mammary Arteries
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2003;
23(3):
425 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Forrester
Prevention of Plaque Rupture: A New Paradigm of Therapy
Ann Intern Med,
November 19, 2002;
137(10):
823 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Adams, J. L. Jones, R. A. Walker, J. H. Pringle, and S. C. Bell
Changes in Tenascin-C Isoform Expression in Invasive and Preinvasive Breast Disease
Cancer Res.,
June 1, 2002;
62(11):
3289 - 3297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wallner, B. G. Sharifi, P. K. Shah, S. Noguchi, H. DeLeon, and J. N. Wilcox
Adventitial remodeling after angioplasty is associated with expression of tenascin mRNA by adventitial myofibroblasts
J. Am. Coll. Cardiol.,
February 1, 2001;
37(2):
655 - 661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wallner, C. Li, M. C. Fishbein, P. K. Shah, and B. G. Sharifi
Arterialization of human vein grafts is associated with tenascin-C expression
J. Am. Coll. Cardiol.,
September 1, 1999;
34(3):
871 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wallner, C. Li, P. K. Shah, M. C. Fishbein, J. S. Forrester, S. Kaul, and B. G. Sharifi
Tenascin-C Is Expressed in Macrophage-Rich Human Coronary Atherosclerotic Plaque
Circulation,
March 16, 1999;
99(10):
1284 - 1289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lauren, Y. Gunji, and K. Alitalo
Is Angiopoietin-2 Necessary for the Initiation of Tumor Angiogenesis?
Am. J. Pathol.,
November 1, 1998;
153(5):
1333 - 1339.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yokoyama, H. P. Erickson, Y. Ikeda, and Y. Takada
Identification of Amino Acid Sequences in Fibrinogen gamma -Chain and Tenascin C C-terminal Domains Critical for Binding to Integrin alpha vbeta 3
J. Biol. Chem.,
May 26, 2000;
275(22):
16891 - 16898.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|